Atlassian: 30% Pop on Real Cloud Proof, but FY27 Growth Is Guided Roughly in Half

Atlassian: 30% Pop on Real Cloud Proof, but FY27 Growth Is Guided Roughly in Half

Atlassian's chief accounting officer, Gene Liu, sold 1,125 Class A shares at $175 on Aug. 19 — about $197,000, roughly 2% of a stake that still stood at 56,807 shares after the sale. The trade was disclosed as part of a pre-arranged 10b5-1 plan, and it landed two weeks after the shares jumped more than 30% on the company's fiscal fourth-quarter report. The CFO, James Chuong, sold about 9,000 shares the same week, disclosed as covering RSU tax withholding. Insider sales around a pop make a good headline and a bad signal; this one says nothing about the business, and the safe read is to ignore it. The useful read is what the pop itself means for the next two quarters: has the market paid up for Atlassian's next phase before the numbers prove it? The honest answer is "partly, and the September-quarter report decides the rest."

The quarter the market paid for was genuinely strong. Cloud revenue rose 31% to $1.213 billion, accelerating from 26% growth in the December quarter and 29% in March. Remaining performance obligations — contracted revenue not yet on the income statement — grew 44% to $4.817 billion, the strongest forward indicator in the release. GAAP operating margin improved to 12% from -2%, GAAP net income swung to $139 million from a $24 million loss, and free cash flow rose 32% to $475 million. Subscription ARR reached $6.606 billion, up 23%. Management added color: its largest deal ever signed, and users of its Rovo AI assistant spending at more than twice the rate of non-users.

Then came the part of a release that a 30% move usually punishes rather than rewards. Fiscal 2027 guidance calls for total revenue growth of roughly 13% — about half of fiscal 2026's 26% — with subscription ARR growth stepping down to about 18% from 23%. Non-GAAP operating margin is guided near 25%, below the roughly 28% the Street was modeling and below fiscal 2026's 30%. Data center revenue, which still grew 21% in the quarter, is guided to fall about 17% as the pull-forward effect of a September 2025 pricing announcement unwinds.

Management's defense is timing, not demand: data center buying was pulled into fiscal 2026, the DX acquisition stops adding a point, and second-half comparisons tighten. The CEO's version is the whole argument in one line — total revenue growth will "trough" this year and re-accelerate in fiscal 2028. The market is therefore being asked to pay today for the quarter behind it plus the re-acceleration that next fiscal year's numbers are supposed to restore.

The price already embeds that bet. The stock has roughly doubled, from about $93 in mid-July to about $172 now, and has more than tripled from an April low near $56, where software-disruption fear had priced it like a company AI would kill. Market cap is about $43.5 billion: roughly 6.6x trailing revenue, about 6x guided FY27 revenue, and about 29x fiscal 2026 adjusted EPS of roughly $5.85. For calibration, Salesforce — growing about 11% — trades near 4x trailing sales; HubSpot, growing about 21%, near 3.5x; monday.com, growing about 24%, under 3x. Atlassian carries the group's richest multiple while guiding the lowest near-term total growth of the four. Wall Street has gone along, with average price targets near $245 and Morningstar's fair value at $220 — which is how you can tell the bull case has become the base case rather than the compensation for carrying the risk.

So the decision lives in the next report. Fiscal Q1, the September quarter, is guided to cloud growth of about 28.5%, revenue of about $1.71 billion, and a non-GAAP operating margin near 28.5%. The print answers three questions: does cloud hold the high-20s after re-accelerating; does RPO stay in the 40s and begin converting; does revenue overrun the guide as it did this quarter, when it cleared the top of guidance by about 6%.

The falsifier is just as specific. If cloud slips toward the low 20s, the "timing, not demand" defense loses its footing — a demand problem plus a 25% margin guide plus a stock that just doubled is a bad combination in a sector already de-rated once on AI fear. If Atlassian keeps beating the way it has, then roughly 6x sales is how you pay up for a re-accelerating compounder, and it works. The wait between this guide and that proof is the whole trade.

None of this turns on the CAO's $197,000. The business genuinely turned: cloud re-accelerated for three straight quarters, backlog is growing 44%, GAAP profit has arrived, and the balance sheet is net cash with free cash flow of about $1.3 billion a year. That is not the company that traded below $60 in April, and the market was right to stop pricing it like a business AI would kill. But the price has already collected the fear-adjusted recovery, and the company's own guide says the growth you would be funding now is about to halve before it re-accelerates. When a good company runs this far this fast on a guide it just cut, the reward for fresh capital runs through the next evidence window, not this month's chart. Existing holders have a named test — cloud in the high-20s, RPO converting, margins delivered — to hold against. New buyers get better odds by waiting for that print to confirm the deceleration is timing, not demand. If it is real timing, the FY28 re-acceleration compounder the Street is reaching for may well be worth roughly 6x sales. If it isn't, a doubled stock with a halved guide corrects faster than a thesis does.